Market Place
Sourcing Support
All News #Library
Generics
Genentech`s Giredestrant Shows Superior iDFS in Breast Cancer
18 Nov 2025 //
BUSINESSWIRE
Genentech’s Gazyva Shows Superiority in Active Lupus Nephritis
07 Feb 2025 //
BUSINESSWIRE
Roche sues Novartis unit over generic lung disease drug
02 Aug 2023 //
REUTERS
Litigation Update: Genentech’s Motion to Dismiss Amgen’s Counterclaims
14 Feb 2020 //
BIGMOLECULEWATCH
Mylan Expands Oncology Portfolio with Launch of Generic Tarceva® Tablets
11 May 2019 //
PR NEWSWIRE
Esbriet® (pirfenidone) : Genentech vs. Teva Pharmaceuticals
30 Jan 2019 //
PATENT LITIGATION
Esbriet® (pirfenidone) : Genentech vs. Accord Healthcare
30 Jan 2019 //
PATENT LITIGATION
Esbriet® (pirfenidone) : Genentech vs. Macleods Pharmaceuticals
30 Jan 2019 //
PATENT LITIGATION
Esbriet® (pirfenidone) : Genentech vs. Aurobindo Pharma
29 Jan 2019 //
PATENT LITIGATION
Esbriet® (pirfenidone) : Genentech vs. ScieGen Pharmaceuticals
29 Jan 2019 //
PATENT LITIGATION
Esbriet® (pirfenidone) : Genentech vs. Laurus Labs
15 Jan 2019 //
PATENT LITIGATION
Herceptin® (Trastuzumab) : Genentech v. Samsung Bioepis
07 Sep 2018 //
PATENT LITIGATION
BPCIA Litigation Updates: Bevacizumab, Trastuzumab, Filgrastim
17 Aug 2018 //
BIGMOLECULEWATCH
I-MAK Report Calls AbbVie "The Worst Patent Offender" in Pharma
07 Aug 2018 //
CENTER FOR BIOSIMILARS
Patent abuse driving high drug prices, non-profit claims
02 Aug 2018 //
LIFESCIENCE PREVIEW
Tarceva¨ (erlotinib HCl): OSI Pharmaceuticals et al v. Shilpa Medicare Limited
26 Jul 2018 //
PATENT LITIGATION
Herceptin® (Trastuzumab) :Genentech, Inc. et al v. Celltrion, Inc. et al
16 Jul 2018 //
PATENT LITIGATION
Rituxan® (Rituximab): Genentech, Inc. et al v. Celltrion, Inc. et al
16 Jul 2018 //
PATENT LITIGATION
Taltz®(ixekizumab): Genentech, Inc. v. Eli Lilly and Company
02 Jul 2018 //
PATENT LITIGATION
Rituxan®(Rituximab): Genentech v. Celltrion
12 Jan 2018 //
PATENT LITIGATION
Tecentriq (Atezolizumab): Bristol-Myers Squibb Co. Et Al V.Genentech,
26 Jul 2017 //
PATENT LITIGATION
Advate (Factor IX): Baxalta V. Genentech, Inc. & Chugai Pharmaceutical
04 May 2017 //
PATENT LITIGATION
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.